BASF issued the following news release: Katja Scharpwinkel and Anup Kothari to become members of the Board of Executive Directors; Melanie Maas-Brunner will not renew her contract beyond 2024. Effective at the end of the Annual Shareholders' Meeting on April 25, 2024, Dr. Markus Kamieth (53) will take over as Chairman of the Board of Executive Directors of BASF SE. This was decided by the Supervisory Board in its meeting on December 20, 2023.

Markus Kamieth has been a member of the Board of Executive Directors since 2017. He succeeds Dr. Martin Brudermuller (62), who has been Chairman of the Board of Executive Directors since 2018 and has been a member of the Board of Executive Directors since 2006. The Supervisory Board has appointed Anup Kothari (55), currently President of the Nutrition & Health division, to the Board of Executive Directors effective March 1, 2024.

Anup Kothari began his career at BASF in North America and has held various positions in the United States, Germany and China in different divisions. The Supervisory Board has appointed Dr. Katja Scharpwinkel (54) to the Board of Executive Directors and Industrial Relations Director effective February 1, 2024. She is currently President of the Europe, Middle East, Africa region.

In 2010, she joined BASF following the acquisition of the former Cognis and has successfully led various businesses since that time. Katja Scharpwinkel succeeds Dr. Melanie Maas-Brunner (55) who informed the Supervisory Board that she will not extend her current contract which runs until January 31, 2024. The Supervisory Board has extended the contract of Michael Heinz (59), member of the Board of Executive Directors of BASF SE, until the Annual Shareholders' Meeting in 2026.

Michael Heinz has been a member of the Board of Executive Directors since 2011. He is responsible for the Agricultural Solutions, Nutrition & Health and Care Chemicals divisions as well as the North America and South America regions.